Yee-Jen Wu
Overview
Explore the profile of Yee-Jen Wu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
7
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Russell Chien T, Chang Y, Weng S, Wu Y, Wang S, Hsu W
Comput Biol Med
. 2025 Jan;
186:109667.
PMID: 39826298
Background: Sacubitril/valsartan (S/V) reduces mortality and hospitalization rates in patients with heart failure with reduced ejection fraction (HFrEF), but low adherence remains a challenge. Early initiation of S/V is recommended,...
2.
Wu Y, Wu C, Huang H, Wu C, Huang C, Wang C
J Thromb Thrombolysis
. 2024 Mar;
57(4):537-546.
PMID: 38555552
Low-dose prasugrel demonstrated a similar effectiveness profile to clopidogrel in East Asian ACS patients, but its comparison with another new-generation potent P2Y inhibitor, ticagrelor, remains unclear. To compare the effectiveness...
3.
Lin S, Chen Y, Kang H, Wu Y, Chen P, Wu C, et al.
Postgrad Med
. 2021 Jun;
133(8):964-973.
PMID: 34180349
The study aimed to evaluate the improvement of patient knowledge of warfarin use, satisfaction with pharmacists, and the quality of international normalized ratio (INR) control after the implementation of an...
4.
Chen P, Wu Y, Wu C, Wang Y
Case Rep Hematol
. 2018 Jul;
2018:4938797.
PMID: 29984015
A 41-year-old man with newly diagnosed acute promyelocytic leukemia (APL) received induction chemotherapy, containing all- retinoic acid (ATRA), idarubicin, and arsenic trioxide. On the 11th day of therapy, he experienced...
5.
Wu C, Wu Y, Wu C
Am J Ther
. 2015 Mar;
23(5):e1197-201.
PMID: 25782570
Clopidogrel is a second generation of thienopyridine, which has antiplatelet effect by inhibiting P2Y12 receptor. Hematologic adverse effect is very uncommon during clopidogrel use, but some cases of clopidogrel-associated neutropenia...